Literature DB >> 2395868

Antibody remodeling: a general solution to the design of a metal-coordination site in an antibody binding pocket.

V A Roberts1, B L Iverson, S A Iverson, S J Benkovic, R A Lerner, E D Getzoff, J A Tainer.   

Abstract

To develop a general approach to designing cofactor-binding sites for catalytic antibodies, we characterized structural patterns in the binding sites of antibodies and zinc enzymes. Superposition of eight sets of antibody light- and heavy-chain variable domains identified structurally conserved sites within the sequence-variable complementarity determining regions. The pattern for catalytic zinc sites included two ligands close in sequence, a sequence-distant ligand, and a main-chain hydrogen bond joining two ligands. In both the light- and heavy-chain variable domains, the stereochemistry of five structurally conserved sites general to all known antibody structures matched that of the zinc ligands of carbonic anhydrase: three residues on two hydrogen-bonded antiparallel beta-strands. For one such general site, an antibody model replacing residue 34 on the first complementarity determining region of the light chain (L1) and residues 89 and 91 on the third complementarity determining region of the light chain (L3) with histidine ligands formed a zinc-binding site with an open coordination position at the bottom of the antibody binding pocket. For the anti-fluorescein antibody 4-4-20, this L1-L3 site placed the zinc ion about 4 A from the bound fluorescein, an indicator for metal binding. This predicted zinc-binding mutant was created in the single-chain variable domain construct, expressed, and found by fluorescence quenching to bind metal ion with an affinity constant of 10(6) M-1. Thus, our template-based multisite design proved successful for remodeling an antibody to contain a cofactor-binding site, without requiring further mutagenesis and screening. Combination of a specific light or heavy chain containing a catalytic metal site with a library of complementary chains raised to potential substrates or transition state analogs should greatly improve the production of catalytic antibodies with desired activities and specificities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395868      PMCID: PMC54595          DOI: 10.1073/pnas.87.17.6654

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

2.  Three-dimensional structure of an antibody-antigen complex.

Authors:  S Sheriff; E W Silverton; E A Padlan; G H Cohen; S J Smith-Gill; B C Finzel; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

4.  Mechanisms of antibody binding to a protein.

Authors:  E D Getzoff; H M Geysen; S J Rodda; H Alexander; J A Tainer; R A Lerner
Journal:  Science       Date:  1987-03-06       Impact factor: 47.728

5.  Single-chain antigen-binding proteins.

Authors:  R E Bird; K D Hardman; J W Jacobson; S Johnson; B M Kaufman; S M Lee; T Lee; S H Pope; G S Riordan; M Whitlow
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

6.  The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein.

Authors:  J A Tainer; E D Getzoff; H Alexander; R A Houghten; A J Olson; R A Lerner; W A Hendrickson
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

7.  Structure of thermolysin refined at 1.6 A resolution.

Authors:  M A Holmes; B W Matthews
Journal:  J Mol Biol       Date:  1982-10-05       Impact factor: 5.469

8.  Refined crystal structure of carboxypeptidase A at 1.54 A resolution.

Authors:  D C Rees; M Lewis; W N Lipscomb
Journal:  J Mol Biol       Date:  1983-08-05       Impact factor: 5.469

9.  Crystal structure of neutral protease from Bacillus cereus refined at 3.0 A resolution and comparison with the homologous but more thermostable enzyme thermolysin.

Authors:  R A Pauptit; R Karlsson; D Picot; J A Jenkins; A S Niklaus-Reimer; J N Jansonius
Journal:  J Mol Biol       Date:  1988-02-05       Impact factor: 5.469

10.  Reshaping human antibodies for therapy.

Authors:  L Riechmann; M Clark; H Waldmann; G Winter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

View more
  22 in total

1.  Interfacial metal and antibody recognition.

Authors:  Tongqing Zhou; Dean H Hamer; Wayne A Hendrickson; Quentin J Sattentau; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

Review 2.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

3.  OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffold.

Authors:  Hossein Fazelinia; Patrick C Cirino; Costas D Maranas
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

4.  Monoclonal antibodies specific for mercuric ions.

Authors:  D E Wylie; D Lu; L D Carlson; R Carlson; K F Babacan; S M Schuster; F W Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 5.  On the failure of de novo-designed peptides as biocatalysts.

Authors:  M J Corey; E Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 6.  Emerging critical roles of Fe-S clusters in DNA replication and repair.

Authors:  Jill O Fuss; Chi-Lin Tsai; Justin P Ishida; John A Tainer
Journal:  Biochim Biophys Acta       Date:  2015-02-02

7.  A cofactor approach to copper-dependent catalytic antibodies.

Authors:  Kenneth M Nicholas; Paul Wentworth; Curtis W Harwig; Anita D Wentworth; Asher Shafton; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

8.  A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.

Authors:  M Levi; M Sällberg; U Rudén; D Herlyn; H Maruyama; H Wigzell; J Marks; B Wahren
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

9.  Scorpion toxins as natural scaffolds for protein engineering.

Authors:  C Vita; C Roumestand; F Toma; A Ménez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

Review 10.  Structural biology and diabetes mellitus: molecular pathogenesis and rational drug design.

Authors:  T Blundell; R Hubbard; M A Weiss
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.